Immunotherapy and targeted therapy-the new roadmap in cancer treatment. Ann Transl Med 2019 Oct;7(20):595
Date
12/07/2019Pubmed ID
31807576Pubmed Central ID
PMC6861781DOI
10.21037/atm.2019.05.58Abstract
Immunotherapy is the new frontier in cancer medicine. This manuscript summarizes historical aspect of immunotherapy, particularly its pathway to drug approval as the main therapeutic modality used in clinical medicine. We will discuss the role of immunotherapy in treating various types of cancers and how the treatment landscape once dominated by chemotherapy is rapidly changing.









